Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...
Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.
Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an approach that may lead to new ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
CRISPR Therapeutics (NASDAQ: CRSP) is a pioneering biotech company, but it isn't yet a profitable one. That's why its shares ...
The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, achieving a CAGR of 12.4%. Key growth drivers include advancements in regenerative ...
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
AI-guided genomic tools helped design experimental cancer treatment for a dog, showing collaborative future medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results